Insider Stock Trading History of Roche Robert P Jr


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Roche Robert P Jr since year 2005. The trader's CIK number is 1210193. At the time of this reporting, Roche Robert P Jr is the Director of Antares Pharma Inc . (stock ticker symbol AIS). See this page for all insider trading activities at Antares Pharma Inc .

Note that in the past ROCHE ROBERT P JR also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Roche Robert P Jr since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-03-18 ATRS Antares Pharma Inc Buy 50,000 .72 36,000
2015-08-24 ATRS Antares Pharma Inc Buy 5,000 1.77 8,850
2015-08-13 ATRS Antares Pharma Inc Buy 5,000 1.94 9,700
2014-08-13 ATRS Antares Pharma Inc Buy 5,000 1.96 9,795
2011-09-15 PATH Nupathe Inc. Buy 10,000 2.68 26,800
2008-12-22 CEPH Cephalon Inc Sale 23,920 77.24 1,847,509
2008-12-22 CEPH Cephalon Inc Option Ex 18,319 48.85 894,883
2008-08-11 CEPH Cephalon Inc Option Ex 21,676 49.11 1,064,573
2008-08-11 CEPH Cephalon Inc Sale 21,676 76.96 1,668,184
2007-12-21 CEPH Cephalon Inc Sale 7,185 72.62 521,745
2007-12-10 CEPH Cephalon Inc Option Ex 2,074 48.20 99,966
2007-12-12 CEPH Cephalon Inc Option Ex 34,176 49.63 1,696,052
2007-12-12 CEPH Cephalon Inc Sale 7,937 76.07 603,767
2007-12-12 CEPH Cephalon Inc Sale 26,239 75.82 1,989,309
2007-12-10 CEPH Cephalon Inc Sale 1,347 78.56 105,813
2007-11-28 CEPH Cephalon Inc Sale 5,255 75.35 395,943
2006-12-22 CEPH Cephalon Inc Sale 3,385 69.75 236,103
2006-12-21 CEPH Cephalon Inc Sale 5,000 69.75 348,750
2006-03-01 CEPH Cephalon Inc Option Ex 80,500 50.13 4,035,787
2006-03-01 CEPH Cephalon Inc Sale 80,500 80.22 6,458,112
2006-02-17 CEPH Cephalon Inc Option Ex 23,700 15.33 363,392
2006-02-17 CEPH Cephalon Inc Sale 30,550 74.09 2,263,449
2005-09-19 CEPH Cephalon Inc Sale 2,500 45.76 114,412

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roche Robert P Jr (Director of Antares Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.